Sign in

    Harrison Parson

    Research Analyst at Stephens

    Harrison Parsons is an Equity Research Associate at Stephens, specializing in coverage of Diagnostics, Genomics & Proteomics companies. Over the past three years and seven months, Parsons has contributed research focused on the financial services sector, leveraging his BSBA in Financial Management and Investments with a minor in Economics from the University of Arkansas. Since joining Stephens, he has applied analytic expertise to support institutional equities and research though detailed company assessments, with a professional tenure exclusively at Stephens following graduation. Parsons holds a bachelor's credential and concentrates on rigorous, sector-specific equity research in the life sciences domain.

    Harrison Parson's questions to CUTR leadership

    Harrison Parson's questions to CUTR leadership • Q2 2024

    Question

    Asked for a breakdown of the drivers behind the reduced revenue guidance (sales force turnover vs. macro) and for clarity on the expected cash burn cadence for the rest of the year and into 2025.

    Answer

    The revenue guidance cut was driven roughly equally by macro pressures and significant North American sales force turnover. Cash burn will be lower in H2 2024 than H1, but a significant improvement is expected in 2025 due to a delayed working capital benefit, cost savings, and planned growth. The Q4 2024 burn rate is not a good proxy for 2025.

    Ask Fintool Equity Research AI